drug
(antihemophilic factor (human) + von willebrand factor complex (human))
Marketedupdated 3mo agoby Octapharma USA Inc
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying (antihemophilic factor (human) + von willebrand factor complex (human))
- phase3Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease (VWD) Patients <6 Years of Age
- —Von Willebrand Factor in Pregnancy (VIP) Study
- —Treatment of Hemophilia A Patients With FVIII Inhibitors
- —Effectiveness and Tolerability of Eqwilate in Real-life Conditions
- —Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq
- phase3Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 39m ago
Found something off?
comments(0)
5-min edit window · permanent after that